Success Story: With Premium Processing, Sudanese Assistant Professor Secures NIW Approval with Ease

Client’s Testimonial:

“Thank you very much for the exciting news, and I appreciate your support and assistance throughout the process. I want to express my heartfelt gratitude to Chen Immigration for their exceptional professionalism in managing my case and for their rapid, thorough responses to my inquiries.”

On March 25^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Restorative Dentistry (Approval Notice).

General Field: Restorative Dentistry

Position at the Time of Case Filing: Assistant Professor

Country of Origin: Sudan

Country of Residence at the time of filing: Saudi Arabia

Approval Notice Date: March 25^th, 2025

Processing Time: 2 months, 1 day (Premium Processing Requested)

Case Summary:

We are excited to share the successful outcome of an EB-2 NIW (National Interest Waiver) petition for a distinguished expert in restorative dentistry. The petitioner, who holds a Ph.D. in the field, is currently contributing to advanced research initiatives in the United States. With a focus on developing innovative bioactive dental materials, his work addresses some of the most urgent challenges in endodontics, restorative procedures, and prosthodontics by leveraging sustainable materials and cutting-edge nanotechnology.

Research on Bioactive Dental Materials with National Impact

The petitioner’s research is centered on synthesizing and characterizing nanoparticle-based dental materials that offer improved antibacterial properties, enhanced biocompatibility, and reduced environmental impact. These advancements are directly applicable to the treatment of dental diseases affecting millions and align with national healthcare priorities, including efforts to combat antibiotic resistance and reduce healthcare costs through preventative solutions. His projects include the development of antimicrobial root canal agents, safer and more effective bleaching gels, and bioactive resins, all designed to improve oral health outcomes while minimizing adverse effects.

Recognized Scholarship and Scientific Contributions

To demonstrate his qualification for a National Interest Waiver, our team highlighted the petitioner’s strong academic output and impact:

● 5 peer-reviewed journal articles, with 1 additional article accepted for publication;

● 2 first-authored conference abstracts and 2 book chapters;

● A total of 56 citations according to Google Scholar;

● At least 30 completed peer reviews for notable scientific journals in dentistry and biomedical sciences.

Independent Expert Support and Endorsements

To strengthen the petition, we included recommendation letters from other established scholars in dentistry. These experts attested to the petitioner’s originality, methodological rigor, and the broad impact of his research on oral health and biomaterials. These endorsements provided compelling third-party validation of the petitioner’s achievements and future potential.

A Case Strategically Structured for Success

The petition was submitted under the EB-2 NIW category with premium processing and was approved in just two months. The success of this petition reflects not only the petitioner’s impressive qualifications and scientific record but also the meticulous preparation of the case by our legal team at North America Immigration Law Group (NAILG). We are proud to have supported this expert in securing approval and look forward to his continued contributions to the advancement of restorative dentistry and public health in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.